Patent: 5,556,940
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Summary for Patent: 5,556,940
Title: | Parathyroid hormone analogues for the treatment of osteoporosis |
Abstract: | Certain analogues of human parathyroid hormone (hPTH) have been found to be effective for the treatment of osteoporosis, while showing decreased side effects. Analogues showing this effect include all sequences from hPTH-(1-28)-NH.sub.2 to hPTH-(1-31)-NH.sub.2 and all sequences from [Leu.sup.27 ]-hPTH-(1-28)-NH.sub.2 to [Leu.sup.27 ]-hPTH-(1-33)-NH.sub.2. Also included are cyclic analogues cyclo(Lys.sup.26 -Asp.sup.30) [Leu.sup.27 ]-hPTH-(1-34)NH.sub.2 and cyclo (Lys.sup.27 -Asp.sup.30 )-hPTH-(1-34)-NH.sub.2. Analogues in the form of the carboxyl terminal amide are particularly effective. |
Inventor(s): | Willick; Gordon E. (Orleans, CA), Whitfield; James F. (Ottawa, CA), Surewicz; Witold (Orleans, CA), Sung; Wing L. (Gloucester, CA), Neugebauer; Witold (Ottawa, CA) |
Assignee: | National Research Council of Canada (Ottawa, CA) |
Application Number: | 08/262,495 |
Patent Claims: | see list of patent claims |
Details for Patent 5,556,940
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Nps Pharmaceuticals, Inc. | NATPARA | parathyroid hormone | For Injection | 125511 | 01/23/2015 | ⤷ Try a Trial | 2039-03-29 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |